Swedish Orphan Biovitrum AB (publ) (STO: SOBI)

SOBI Statistics

Total Valuation

Swedish Orphan Biovitrum AB has a market cap or net worth of SEK 109.61 billion. The enterprise value is 125.94 billion.

Market Cap	109.61B
Enterprise Value	125.94B

Important Dates

The next estimated earnings date is Thursday, October 24, 2024.

Earnings Date	Oct 24, 2024
Ex-Dividend Date	n/a

Share Statistics

Swedish Orphan Biovitrum AB has 342.53 million shares outstanding. The number of shares has increased by 11.41% in one year.

Shares Outstanding	342.53M
Shares Change (YoY)	+11.41%
Shares Change (QoQ)	+0.20%
Owned by Insiders (%)	0.23%
Owned by Institutions (%)	55.77%
Float	218.79M

Valuation Ratios

The trailing PE ratio is 50.98 and the forward PE ratio is 24.66. Swedish Orphan Biovitrum AB's PEG ratio is 0.87.

PE Ratio	50.98
Forward PE	24.66
PS Ratio	4.56
PB Ratio	3.02
P/FCF Ratio	17.32
PEG Ratio	0.87

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.40, with an EV/FCF ratio of 19.91.

EV / Earnings	58.71
EV / Sales	5.31
EV / EBITDA	15.40
EV / EBIT	27.22
EV / FCF	19.91

Financial Position

The company has a current ratio of 0.73, with a Debt / Equity ratio of 47.03.

Current Ratio	0.73
Quick Ratio	0.49
Debt / Equity	47.03
Debt / EBITDA	2.09
Debt / FCF	2.70
Interest Coverage	3.15

Financial Efficiency

Return on equity (ROE) is 6.63% and return on invested capital (ROIC) is 5.26%.

Return on Equity (ROE)	6.63%
Return on Assets (ROA)	3.88%
Return on Capital (ROIC)	5.26%
Revenue Per Employee	13.38M
Profits Per Employee	1.21M
Employee Count	1,772
Asset Turnover	0.32
Inventory Turnover	1.36

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +54.85% in the last 52 weeks. The beta is 0.23, so Swedish Orphan Biovitrum AB's price volatility has been lower than the market average.

Beta (5Y)	0.23
52-Week Price Change	+54.85%
50-Day Moving Average	287.01
200-Day Moving Average	273.00
Relative Strength Index (RSI)	67.23
Average Volume (20 Days)	402,035

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Swedish Orphan Biovitrum AB had revenue of SEK 23.71 billion and earned 2.15 billion in profits. Earnings per share was 6.28.

Revenue	23.71B
Gross Profit	18.42B
Operating Income	4.63B
Pretax Income	2.61B
Net Income	2.15B
EBITDA	8.03B
EBIT	4.63B
Earnings Per Share (EPS)	6.28

Balance Sheet

The company has 779.00 million in cash and 17.10 billion in debt, giving a net cash position of -16.32 billion or -47.64 per share.

Cash & Cash Equivalents	779.00M
Total Debt	17.10B
Net Cash	-16.32B
Net Cash Per Share	-47.64
Equity (Book Value)	36.35B
Book Value Per Share	106.08
Working Capital	-4.35B

Cash Flow

In the last 12 months, operating cash flow was 6.72 billion and capital expenditures -389.00 million, giving a free cash flow of 6.33 billion.

Operating Cash Flow	6.72B
Capital Expenditures	-389.00M
Free Cash Flow	6.33B
FCF Per Share	18.47

Margins

Gross margin is 77.69%, with operating and profit margins of 19.51% and 9.05%.

Gross Margin	77.69%
Operating Margin	19.51%
Pretax Margin	11.02%
Profit Margin	9.05%
EBITDA Margin	33.88%
EBIT Margin	19.51%
FCF Margin	26.68%

Dividends & Yields

Swedish Orphan Biovitrum AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.41%
Shareholder Yield	-11.41%
Earnings Yield	1.96%
FCF Yield	5.77%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a